Royce & Associates LP’s Enovis Corporation Position
Does Royce & Associates LP own Enovis Corporation (ENOV)? Yes — 611.1K shares worth $14M (+0.14% of its 13F portfolio) as of Q1 2026, down from 826.8K shares the prior filed quarter.
Position Value
$14M
Q1 2026
Shares
611.1K
% of Portfolio
+0.14%
Quarters Held
16
currently held
Position History ENOV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 611.1K | $14M | +0.14% |
| Q4 2025 | 826.8K | $22M | +0.22% |
| Q3 2025 | 721.2K | $22M | +0.22% |
| Q2 2025 | 2.42M | $76M | +0.78% |
| Q1 2025 | 2.49M | $95M | +1.03% |
| Q4 2024 | 2.47M | $108M | +1.01% |
| Q3 2024 | 2.40M | $103M | +0.94% |
| Q2 2024 | 2.06M | $93M | +0.87% |
| Q1 2024 | 1.60M | $100M | +0.89% |
| Q4 2023 | 1.59M | $89M | +0.82% |
| Q3 2023 | 1.35M | $71M | +0.73% |
| Q2 2023 | 1.11M | $71M | +0.69% |
| Q1 2023 | 1.11M | $60M | +0.60% |
| Q4 2022 | 1.12M | $59,783 | +0.62% |
| Q3 2022 | 989.2K | $46M | +0.52% |
| Q2 2022 | 625.3K | $34M | +0.35% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Royce & Associates LP’s full portfolio or all institutional holders of ENOV.